mHealth Intervention in Increasing HPV Vaccinations in College Students

Ohio State University Comprehensive Cancer Center101 enrolled

Overview

This randomized pilot trial studies how well a mobile health (mHealth) intervention works in increasing human papillomavirus (HPV) vaccination among college students at the Ohio State University. mHealth educational intervention may communicate information about HPV vaccination and increase HPV vaccine uptake in college students.

PRIMARY OBJECTIVES: I. Pilot test an mHealth HPV vaccine intervention for college students to establish feasibility and acceptability. II. Obtain preliminary efficacy data on whether the mHealth HPV vaccine intervention increases HPV vaccine initiation compared to the control group. SECONDARY OBJECTIVES: I. Examine whether the mHealth HPV vaccine intervention affects secondary outcomes compared to the control group. OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants receive targeted HPV vaccine narrative-style video via the mobile-friendly website. Participants also receive monthly HPV vaccination reminders via email or by text message. ARM II: Participants receive standard information about HPV and then HPV vaccine information statement (VIS) via the mobile-friendly website. After completion of study, participants are followed up at 3 and 7 months.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

101

Conditions

Healthy Subject

Interventions

Informational InterventionOTHER

Receive standard HPV vaccine information (HPV VIS)

Media InterventionOTHER

Receive targeted HPV vaccine narrative-style video

Survey AdministrationOTHER

Ancillary studies

Eligibility

Sex: ALLMin age: 18 YearsMax age: 25 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Currently enrolled as a first year Ohio State University (OSU) student on the Columbus campus * Being able to read English * Not having received any doses of the HPV vaccine

Locations (1)

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, United States

Outcomes

Primary Outcomes

Receipt of the first dose of HPV vaccine in intervention and control group

Will obtain preliminary efficacy data on whether the mHealth HPV vaccine intervention increases HPV vaccine initiation compared to the control group.

Time frame: Up to 7 months

Participant satisfaction scores

Acceptability and feasibility will be established by examining participant satisfaction with study materials.

Time frame: Up to 7 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.